Fortfahren mit
89921
(±)-2,4-Dihydroxybuttersäure Lithiumsalz
≥95.0% (GC)
Synonym(e):
2,4-Dihydroxybutansäure Lithiumsalz
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 10 mg | Warenkorb auf Verfügbarkeit prüfen | € 222,00 | |
| 50 mg | Warenkorb auf Verfügbarkeit prüfen | € 445,00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C4H8O4
CAS-Nummer:
Molekulargewicht:
120.10
MDL number:
UNSPSC Code:
12352106
PubChem Substance ID:
NACRES:
NA.24
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenQuality Level
assay
≥95.0% (GC)
application(s)
clinical testing
format
neat
storage temp.
2-8°C
SMILES string
OC(CCO)C(=O)O
InChI
1S/C4H8O4/c5-2-1-3(6)4(7)8/h3,5-6H,1-2H2,(H,7,8)
InChI key
UFYGCFHQAXXBCF-UHFFFAOYSA-N
Biochem/physiol Actions
Various cases of succinic semialdehyde dehydrogenase deficiency have shown consistently increased amounts of this metabolite, while 2,4-dihydroxybutanoic acid is usually absent in normal human urine extracts or in only trace constituents in neonates.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| format neat | format neat | format neat | format - |
| assay ≥95.0% (GC) | assay ≥95% (HPCE) | assay ≥95.0% (HPLC) | assay ≥90.0% (HPLC) |
| storage temp. 2-8°C | storage temp. −20°C | storage temp. −20°C | storage temp. 2-8°C |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level - |
| application(s) clinical testing | application(s) clinical testing | application(s) clinical testing | application(s) clinical testing |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
M Orešič et al.
Translational psychiatry, 1, e57-e57 (2011-01-01)
Mild cognitive impairment (MCI) is considered as a transition phase between normal aging and Alzheimer's disease (AD). MCI confers an increased risk of developing AD, although the state is heterogeneous with several possible outcomes, including even improvement back to normal
G K Brown et al.
Journal of inherited metabolic disease, 10(4), 367-375 (1987-01-01)
In addition to the previously reported abnormalities, urine extracts from three cases of succinic semialdehyde dehydrogenase deficiency have shown consistently increased amounts of 2,4-dihydroxybutyric acid, and its lactone, and 3-hydroxypropionic acid, metabolites related to the alpha-oxidation of 4-hydroxybutyric acid. Threo-
J A Thompson et al.
Clinical chemistry, 21(13), 1892-1898 (1975-12-01)
Gas chromatographic/mass spectrometric/computer analyses of trimethylsilyl derivatives of urine extracts, prepared by an anion-exchange procedure, reveal the presence of several tetronic and deoxytetronic acids. Identifications were confirmed by comparing gas-chromatographic methylene unit values and mass spectrometric characteristics with those of
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 89921-50MG | 04061833416099 |
| 89921-10MG | 04061833077368 |